KENAN OSMANOVIC: Open Payments
NPI 1396996708 · SHREWSBURY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$229 in 11 payments from 8 companies in 2025. Trend: 2023 $156 · 2024 $290 · 2025 $229
Food & beverage: $229
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 3 | $47 |
| Corium, LLC | 2 | $42 |
| Supernus Pharmaceuticals, Inc. | 1 | $37 |
| Alkermes, Inc. | 1 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Indivior Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: Jornay PM, Azstarys, Qelbree, ARISTADA, INGREZZA, INVEGA SUSTENNA, SUBLOCADE, REXULTI.
Industry payments across NJ — which companies pay providers there.
